So, Quizartinib is this FLT3 inhibitor thing. It’s mainly used for people who’ve had their acute myeloid leukemia come back or not respond to treatment, especially if they have these FLT3-ITD mutations. It stops FLT3 signaling in its tracks.
There are two doses available, 17.7 mg and 26.5 mg, and they come as film-coated tablets. For adults, the usual dose is 53 mg, taken once a day, but after a bit of a starting phase. Each bottle of Quizartinib has 28 tablets in it.
Reviews
There are no reviews yet.